Results 141 to 150 of about 3,210,025 (200)

The governance of imported 2019-nCov infections: What can be learned from China's experience? [PDF]

open access: yesGlob Health Res Policy, 2022
Li H   +5 more
europepmc   +1 more source

Circular externa No 005 de 2020

open access: yes, 2020
Directrices para la detección temprana, el control y la atención ante la posible introducción del nuevo coronavirus (2019-nCOV) y la implementación de los planes de preparación y respuesta ante este ...
Ministerio de Salud y Protección Social
core  

2019-nCoV FAQs

open access: yes
Disease Basics -- Prevention -- Medical Information -- Public Health Response and Current Situation -- Travel -- 2019-nCoV and Animals ...

core  

What you need to know about 2019 novel coronavirus (2019-nCoV) [PDF]

open access: yes
For more information: www.cdc.gov/nCoVCS 314937-A2019-ncov-factsheet.pdfWhat is 2019 novel coronavirus? -- Can people in the U.S. get 2019-nCoV? -- Have there been cases of 2019-nCoV in the U.S.? -- How does 2019-nCoV spread?

core  

Viability And Infectivity Of Coronavirus (2019-nCoV)

open access: yes, 2020
: 2019-nCoV is one of the seven human coronaviruses responsible for causing COVID-19. The disease started in Wuhan China and was declared a global pandemic by the World Health Organization because of high number of confirmed COVID-19 cases and deaths
Samuel, Mwesige
core  

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice. [PDF]

open access: yesFront Immunol, 2023
Li X   +21 more
europepmc   +1 more source

Inhibitory Effect of Baicalin on 2019-NCOV Invasion

open access: yes, 2022
Geng X, Zhou M, Sun R, Wei X, Zhu Q.
europepmc   +1 more source

Clinical evaluation of anterior nasal cavity swab specimens by a rapid antigen test using a GLINE-2019-nCoV Ag Kit to diagnose COVID-19. [PDF]

open access: yesJ Infect Chemother, 2023
Ogane K   +12 more
europepmc   +1 more source

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

open access: yes, 2020
Given the scale and rapid spread of the 2019 novel coronavirus (2019-nCoV) acute respiratory disease, there is an immediate need for medicines that can help before a vaccine can be produced.
Justin Stebbing (181883)   +8 more
core  

Home - About - Disclaimer - Privacy